Subscribe to RSS
DOI: 10.1055/s-2007-967058
© Georg Thieme Verlag KG Stuttgart · New York
Management of severe chest pain caused by a Bravo pH monitoring capsule
Publication History
Publication Date:
26 February 2008 (online)
Continuous ambulatory pH-metry with the Bravo “catheter-free” monitoring system (Medtronic, Minneapolis, Minnesota, USA) is becoming more and more popular [1] [2] [3]. As experience with this technique has grown, it has become evident that up to 50 % of patients report mild chest pain [2] [3] [4] or even severe chest pain requiring endoscopic removal of the capsule [3] [5]. We have also had three patients with insupportably severe chest pain that occurred 2 – 3 hours after placement of a Bravo capsule. Because treatment with analgesics was ineffective we decided to remove the first capsule after 2 days. The pain ceased promptly. On the basis of our experience with this patient, we removed the capsules immediately after completion of 24 hours of recording in the other two patients.
We tried to remove the first capsule ([Fig. 1]) by exerting gentle pressure with the tip of the endoscope [5], grasping it with a biopsy forceps in an attempt to push it off the mucosa [3]. However, the capsule was attached too firmly and could not be dislodged. We eventually placed a polypectomy snare around the capsule ([Fig. 2]) and were able to detach it easily from the esophageal wall with electrocautery. The capsule was recovered using the same snare ([Fig. 3]), leaving only a small mucosal defect similar to that left after a small mucosectomy ([Fig. 4]). This procedure appears to be fairly safe because only mucosa and not the whole esophageal wall can be aspirated due to the small size of the vacuum well in the capsule ([Fig. 5]). Detaching the capsule with a polypectomy snare would therefore be very unlikely to cause an iatrogenic esophageal perforation. Furthermore, no bleeding will occur due to the electrocautery.
Fig. 1 Endoscopic view of a correctly attached Bravo capsule.
Fig. 2 A polypectomy snare (1) positioned around the site of fixation of the Bravo capsule to the esophageal wall (2).
Fig. 3 The polypectomy snare (1) is used to recover the detached Bravo capsule (2).
Fig. 4 The superficial mucosal defect (arrow) left after detachment of the Bravo capsule with an endoscopic polypectomy snare.
Fig. 5 The detached Bravo capsule with esophageal mucosa in the vacuum well (arrow).
Endoscopic removal of the capsule with a polypectomy snare is a reasonable treatment strategy in the event of capsule-induced severe chest pain. This method seems safe and prevents bleeding from the mucosa.
Endoscopy_UCTN_Code_CPL_1AH_2AJ
References
- 1 Gillies R S, Stratford J M, Booth M I, Dehn T C. Oesophageal pH monitoring using the Bravo catheter-free radio capsule. Eur J Gastroenterol Hepatol. 2007; 1 57-63
- 2 Wong W M, Bautista J, Dekel R. et al . Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring: a randomized trial. Aliment Pharmacol Ther. 2005; 2 155-163
- 3 Pandolfino J E, Richter J E, Ours T. et al . Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol. 2003; 4 740-749
- 4 Lee Y C, Wang H P, Chiu H M. et al . Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring. Gastrointest Endosc. 2005; 6 834-841
- 5 Triester S L, Leighton J A, Budavari A I. et al . Severe chest pain from an indwelling Bravo pH probe. Gastrointest Endosc. 2005; 2 317-319
A. Fischer, MD
Surgical Endoscopy
Department of General and Visceral Surgery
Albert-Ludwigs-University
Hugstetterstr. 55
79106 Freiburg
Germany
Fax: +49-7612702570
Email: andreas.fischer@uniklinik-freiburg.de